心肺ストレステストシステムの世界市場2017-2025:製品タイプ別(心肺運動検査(CPET)システム、ストレスECG、パルスオキシメータ、ストレス血圧モニター、単一光子放射型コンピューター断層撮影(SPECT))、エンドユーザー別

◆英語タイトル:Cardiopulmonary Stress Testing Systems Market (Product Type - Cardiopulmonary Exercise Testing (CPET) Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography (SPECT); End-user - Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
◆商品コード:TMR20NV17
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2020年10月16日
◆ページ数:200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥602,680見積依頼/購入/質問フォーム
Multi User(5名様閲覧)USD8,795 ⇒換算¥914,680見積依頼/購入/質問フォーム
Corporate License(法人閲覧)USD11,795 ⇒換算¥1,226,680見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Transparency Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、心肺ストレステストシステムの世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、製品タイプ別(心肺運動検査(CPET)システム、ストレスECG、パルスオキシメータ、ストレス血圧モニター、単一光子放射型コンピューター断層撮影(SPECT))分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの項目を掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場動向
・キーインサイト
・心肺ストレステストシステムの世界市場規模:製品タイプ別(心肺運動検査(CPET)システム、ストレスECG、パルスオキシメータ、ストレス血圧モニター、単一光子放射型コンピューター断層撮影(SPECT))
・心肺ストレステストシステムの世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況
【レポートの概要】

Global Cardiopulmonary Stress Testing Systems Market – Scope of Report

TMR’s report on the global cardiopulmonary stress testing systems market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cardiopulmonary stress testing systems market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cardiopulmonary stress testing systems market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cardiopulmonary stress testing systems market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global cardiopulmonary stress testing systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cardiopulmonary stress testing systems market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cardiopulmonary stress testing systems market.

The report delves into the competitive landscape of the global cardiopulmonary stress testing systems market. Key players operating in the global cardiopulmonary stress testing systems market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cardiopulmonary stress testing systems market that have been profiled in this report.

Key Questions Answered in Global Cardiopulmonary Stress Testing Systems Market Report

What is the scope of growth of product companies in the global cardiopulmonary stress testing systems market?
What will be the Y-o-Y growth of the global cardiopulmonary stress testing systems market between 2019 and 2027?
What is the influence of changing trends in technologies on the global cardiopulmonary stress testing systems market?
Will North America continue to be the most profitable market for cardiopulmonary stress testing systems providers?
Which factors are anticipated to hamper the growth of the global cardiopulmonary stress testing systems market during the forecast period?
Which are the leading companies in the global cardiopulmonary stress testing systems market?
Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global cardiopulmonary stress testing systems market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global cardiopulmonary stress testing systems market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the cardiopulmonary stress testing systems market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the cardiopulmonary stress testing systems market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global cardiopulmonary stress testing systems market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global cardiopulmonary stress testing systems market more reliably and accurately.

【レポートの目次】

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiopulmonary Stress Testing Systems Market

4. Market Overview

4.1. Introduction

4.1.1. Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Number of Cardiac Stress Test Procedures Performed from MPI SPECT Test in U.S. and Europe

5.2. Pricing Analysis

5.3. Epidemiology of Coronary Artery Disease, by Key Countries

6. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, by Product Type

6.1. Introduction & Definition

6.1.1. Key Findings / Developments

6.2. Global Cardiopulmonary Stress Testing Systems Market Value Forecast, by Product Type, 2017–2027

6.2.1. CPET Systems

6.2.1.1. Stationary

6.2.1.2. Portable

6.2.2. Stress ECG

6.2.3. Pulse Oximeters

6.2.4. Stress BP Monitors

6.2.5. Single-Photon Emission Computed Tomography (SPECT)

6.3. Global Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type

7. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, by Region

7.1. Key Findings

7.2. Global Cardiopulmonary Stress Testing Systems Market Value Forecast, by Region

7.2.1. North America

7.2.2. Europe

7.2.3. Asia Pacific

7.2.4. Latin America

7.2.5. Middle East & Africa

7.3. North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Region

8. North America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

8.1. Introduction

8.1.1. Key Findings

8.2. North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

8.2.1. CPET Systems

8.2.1.1. Stationary

8.2.1.2. Portable

8.2.2. Stress ECG

8.2.3. Pulse Oximeters

8.2.4. Stress BP Monitors

8.2.5. Single-Photon Emission Computed Tomography (SPECT)

8.3. North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country, 2017–2027

8.3.1. U.S.

8.3.2. Canada

8.4. North America Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

8.4.1. By Product Type

8.4.2. By Country

9. Europe Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

9.2.1. CPET Systems

9.2.1.1. Stationary

9.2.1.2. Portable

9.2.2. Stress ECG

9.2.3. Pulse Oximeters

9.2.4. Stress BP Monitors

9.2.5. Single-Photon Emission Computed Tomography (SPECT)

9.3. Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

9.3.1. Germany

9.3.2. U.K.

9.3.3. France

9.3.4. Spain

9.3.5. Italy

9.3.6. Rest of Europe

9.4. Europe Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

9.4.1. By Product Type

9.4.2. By Country/Sub-region

10. Asia Pacific Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

10.2.1. CPET Systems

10.2.1.1. Stationary

10.2.1.2. Portable

10.2.2. Stress ECG

10.2.3. Pulse Oximeters

10.2.4. Stress BP Monitors

10.2.5. Single-Photon Emission Computed Tomography (SPECT)

10.3. Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. Australia & New Zealand

10.3.5. Rest of Asia Pacific

10.4. Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

10.4.1. By Product Type

10.4.2. By Country/Sub-region

11. Latin America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

11.2.1. CPET Systems

11.2.1.1. Stationary

11.2.1.2. Portable

11.2.2. Stress ECG

11.2.3. Pulse Oximeters

11.2.4. Stress BP Monitors

11.2.5. Single-Photon Emission Computed Tomography (SPECT)

11.3. Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

11.3.1. Brazil

11.3.2. Mexico

11.3.3. Rest of Latin America Latin America

11.4. Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

11.4.1. By Product Type

11.4.2. By Country/Sub-region

12. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

12.2.1. CPET Systems

12.2.1.1. Stationary

12.2.1.2. Portable

12.2.2. Stress ECG

12.2.3. Pulse Oximeters

12.2.4. Stress BP Monitors

12.2.5. Single-Photon Emission Computed Tomography (SPECT)

12.3. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

12.3.1. GCC Countries

12.3.2. South Africa

12.3.3. Rest of Middle East & Africa

12.4. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

12.4.1. By Product Type

12.4.2. By Country/Sub-region

13. Competition Landscape

13.1. Market Player – Competition Matrix (by Tier and Size of companies)

13.2. Market Share / Position Analysis, by Company, 2018

13.3. Company Profiles

13.3.1. General Electric Company

13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.1.2. Financial Overview

13.3.1.3. Strategic Overview

13.3.1.4. SWOT Analysis

13.3.2. Koninklijke Philips N.V.

13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.2.2. Financial Overview

13.3.2.3. Strategic Overview

13.3.2.4. SWOT Analysis

13.3.3. CareFusion Corporation (BD)

13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.3.2. Financial Overview

13.3.3.3. Strategic Overview

13.3.3.4. SWOT Analysis

13.3.4. Spacelabs Healthcare (OSI Systems, Inc.)

13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.4.2. Financial Overview

13.3.4.3. Strategic Overview

13.3.4.4. SWOT Analysis

13.3.5. COSMED srl

13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.5.2. Financial Overview

13.3.5.3. Strategic Overview

13.3.5.4. SWOT Analysis

13.3.6. MGC Diagnostic Corporation

13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.6.2. Financial Overview

13.3.6.3. Strategic Overview

13.3.6.4. SWOT Analysis

13.3.7. Nihon Kohden Corporation

13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.7.2. Financial Overview

13.3.7.3. Strategic Overview

13.3.7.4. SWOT Analysis

13.3.8. Schiller AG

13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.8.2. Financial Overview

13.3.8.3. Strategic Overview

13.3.8.4. SWOT Analysis

13.3.9. SunTech Medical, Inc.

13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.9.2. Financial Overview

13.3.9.3. Strategic Overview

13.3.9.4. SWOT Analysis

13.3.10. Welch Allyn

13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

13.3.10.2. Financial Overview

13.3.10.3. Strategic Overview

13.3.10.4. SWOT Analysis

List of Tables

Table 01.Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 07.Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 08.North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09.North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 15.Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16.Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 22.Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 23.Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 29.Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30.Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 31.Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Passive Approximators, 2017–2027

Table 36.Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 37.Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product, 2017–2027

List of Figure

Figure 01.Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) and Forecast, 2019–2027

Figure 02.Global Cardiopulmonary Stress Testing Systems Market Value Share, by Product Type Type, 2018

Figure 03.Global Cardiopulmonary Stress Testing Systems Market Value Share, by Region, 2018

Figure 04.Global Cardiopulmonary Stress Testing Systems Market Value Share Analysis, by Product Type Type, 2018 and 2027

Figure 05.Global Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis, by Product Type Type, 2018-2027

Figure 06.Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by CPET Systems, 2017–2027

Figure 07.Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by Stress ECG, 2017–2027

Figure 08.Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by Pulse Oximeters, 2017–2027

Figure 09.Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by Stress BP Monitors, 2017–2027

Figure 10.Global Cardiopulmonary Stress Testing Systems Market Revenue (US$ Mn), by Single-Photon Emission Computed Tomography (SPECT), 2017–2027

Figure 11.Global Cardiopulmonary Stress Testing Systems Market Value Share Analysis, by Region, 2018 and 2027

Figure 12.Global Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis, by Region, 2018-2027

Figure 13.North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 14.North America Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country, 2018 and 2027

Figure 15.North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country, 2019–2027

Figure 16.North America Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 17.North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019–2027

Figure 18.Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 19.Europe Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 20.Europe Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 21.Europe Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 22.Europe Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019–2027

Figure 23.Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 24.Asia Pacific Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 25.Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 26.Asia Pacific Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 27.Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019–2027

Figure 28.Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 29.Latin America Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 30.Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 31.Latin America Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 32.Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019–2027

Figure 33.Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 34.Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 35.Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 36.Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value Share (%), by Product Type, 2018 and 2027

Figure 37.Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type, 2019–2027

Figure 38.General Electric Company Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 39.General Electric Company Breakdown of Net Sales (%), by Business Segment, 2018

Figure 40.General Electric Company Breakdown of Net Sales (%), by Region, 2018

Figure 41.General Electric Company R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 42.Koninklijke Philips N.V. Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 43.Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 44.Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region, 2018

Figure 45.Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 46.CareFusion Corporation (BD) Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 47.CareFusion Corporation (BD) Breakdown of Net Sales (%), by Business Segment, 2018

Figure 48.CareFusion Corporation (BD) Breakdown of Net Sales (%), by Region, 2018

Figure 49.CareFusion Corporation (BD) R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 50.Spacelabs Healthcare (OSI Systems, Inc.) Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 51.Spacelabs Healthcare (OSI Systems, Inc.) Breakdown of Net Sales (%), by Business Segment, 2018

Figure 52.Spacelabs Healthcare (OSI Systems, Inc.) Breakdown of Net Sales (%), by Region, 2018

Figure 53.Spacelabs Healthcare (OSI Systems, Inc.) R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 54.COSMED srl Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 55.COSMED srl Breakdown of Net Sales (%), by Business Segment, 2018

Figure 56.COSMED srl Breakdown of Net Sales (%), by Region, 2018

Figure 57.COSMED srl R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 58.MGC Diagnostic Corporation Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 59.MGC Diagnostic Corporation Breakdown of Net Sales (%), by Business Segment, 2018

Figure 60.MGC Diagnostic Corporation Breakdown of Net Sales (%), by Region, 2018

Figure 61.MGC Diagnostic Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 62.Nihon Kohden Corporation Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 63.Nihon Kohden Corporation Breakdown of Net Sales (%), by Business Segment, 2018

Figure 64.Nihon Kohden Corporation Breakdown of Net Sales (%), by Region, 2018

Figure 65.Nihon Kohden Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 66.Schiller AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 67.Schiller AG Breakdown of Net Sales (%), by Business Segment, 2018

Figure 68.Schiller AG Breakdown of Net Sales (%), by Region, 2018

Figure 69.Schiller AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 70.SunTech Medical, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 71.SunTech Medical, Inc. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 72.SunTech Medical, Inc. Breakdown of Net Sales (%), by Region, 2018

Figure 73.SunTech Medical, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 74.Welch Allyn Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2018

Figure 75.Welch Allyn Breakdown of Net Sales (%), by Business Segment, 2018

Figure 76.Welch Allyn Breakdown of Net Sales (%), by Region, 2018

Figure 77.Welch Allyn R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心肺ストレステストシステムの世界市場2017-2025:製品タイプ別(心肺運動検査(CPET)システム、ストレスECG、パルスオキシメータ、ストレス血圧モニター、単一光子放射型コンピューター断層撮影(SPECT))、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆